{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T06:28:08Z","timestamp":1789194488962,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11\/0246"],"award-info":[{"award-number":["PI11\/0246"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003329","name":"Ministerio de Econom\u00eda y Competitividad of Spain","doi-asserted-by":"crossref","award":["SAF2011-23475"],"award-info":[{"award-number":["SAF2011-23475"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"crossref"}]},{"name":"CIBERER","award":["707"],"award-info":[{"award-number":["707"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Health Qual Life Outcomes"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1186\/s12955-017-0586-z","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T13:23:17Z","timestamp":1485177797000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":66,"title":["Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2904-3982","authenticated-orcid":false,"given":"Roberto","family":"Zarrabeitia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepci\u00f3n","family":"Fari\u00f1as-\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Santib\u00e1\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blanca","family":"Se\u00f1aris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fontalba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa Mar\u00eda","family":"Botella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Antonio","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,23]]},"reference":[{"key":"586_CR1","unstructured":"\u201cInternational Classification of diseases (ICD)\u201d. World Health Organization. http:\/\/www.who.int\/classifications\/icd\/en\/ ."},{"key":"586_CR2","unstructured":"\u201cICD-9-CM Diagnosis Codes-International Clssification of Diseases-Medical Diagnosis Codes\u201d. http:\/\/www.findacode.com"},{"key":"586_CR3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1288\/00005537-199109000-00008","volume":"101","author":"OS Aassar","year":"1991","unstructured":"Aassar OS, Friedman CM, White Jr RI. The natural history of epistaxis in hereditary haemorrhagic telangiectasia. Laryngoscope. 1991;101:977\u201380.","journal-title":"Laryngoscope"},{"key":"586_CR4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/ejhg.2009.35","volume":"17","author":"FS Govani","year":"2009","unstructured":"Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. Eur J Hum Genet. 2009;17:860\u201371.","journal-title":"Eur J Hum Genet"},{"key":"586_CR5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13023-014-0115-7","volume":"9","author":"GA Latino","year":"2014","unstructured":"Latino GA, Brown D, Glazier RH, Weyman JT, Faughnan ME. Targeting under diagnosis in hereditary hemorrhagic telangiectasia: a model approach for rare diseases? Orphanet J Rare Dis. 2014;9:115\u201325.","journal-title":"Orphanet J Rare Dis"},{"key":"586_CR6","first-page":"345","volume":"8","author":"AD Kjeldsen","year":"1999","unstructured":"Kjeldsen AD, Vase P, Green A. Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients. J Intern Med. 1999;8:345\u201351.","journal-title":"J Intern Med"},{"key":"586_CR7","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P","volume":"91","author":"CL Shovlin","year":"2000","unstructured":"Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Genet. 2000;91:66\u20137.","journal-title":"Am J Genet"},{"key":"586_CR8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1136\/jmg.2009.069013","volume":"48","author":"ME Faughnan","year":"2011","unstructured":"Faughnan ME, Palda VA, Garcia Tsao G, et al. Internacional guidelines for the diagnosis and management of hereditary hemorrhagic telangiectasia. J Med Genet. 2011;48:73\u201387.","journal-title":"J Med Genet"},{"key":"586_CR9","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-2006-933691","volume":"131","author":"D Slotosch","year":"2006","unstructured":"Slotosch D, Koller M, Werner JA, Foldz BJ. Recurrent nosebleeds in patients with hereditary haemorrhagic telangiectasia. Dtsch Med Wochenschr. 2006;131:535\u20139.","journal-title":"Dtsch Med Wochenschr"},{"key":"586_CR10","first-page":"79","volume":"1","author":"X Bad\u00eda","year":"1999","unstructured":"Bad\u00eda X, Roset M, Montserrat S, Herdman M, Segura A. La versi\u00f3n espa\u00f1ola del Euroqol: descripci\u00f3n y aplicaciones. Med Clin (Barc). 1999;1:79\u201386.","journal-title":"Med Clin (Barc)"},{"key":"586_CR11","series-title":"Proceedings of the EuroQol meeting","first-page":"77","volume-title":"The Spanish EuroQol tariff: results from the Catalan health survey based on self-rating health","author":"M Ru\u00e9","year":"1995","unstructured":"Ru\u00e9 M, Bad\u00eda X. The Spanish EuroQol tariff: results from the Catalan health survey based on self-rating health, Proceedings of the EuroQol meeting. 1995. p. 77\u201398."},{"key":"586_CR12","series-title":"Proceedings of the EuroQol meeting","first-page":"113","volume-title":"Measuring valuations for health states amongst the general population in Navarra (Spain)","author":"I Gaminde","year":"1995","unstructured":"Gaminde I, Casab\u00e9s J. Measuring valuations for health states amongst the general population in Navarra (Spain), Proceedings of the EuroQol meeting. 1995. p. 113\u201320."},{"key":"586_CR13","first-page":"85","volume":"1","author":"EM Gussem De","year":"2009","unstructured":"De Gussem EM, Snijder RJ, Disch FJ, Zanen P, Westermann CJ, Mager JJ. The effect of N-acetylcisteine on epistaxis and quality of life in patients with HHT: a pilot study. Rhinology. 2009;1:85\u20138.","journal-title":"Rhinology"},{"key":"586_CR14","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1002\/lary.23303","volume":"122","author":"S Dheyauldeen","year":"2012","unstructured":"Dheyauldeen S, Ostertun Geirdal A, Osnes T, Varttdal LS, Dollner R. Bevacizumab in hereditary hemorrhagic telangiectasia-associated epistaxis: effectiveness of an injection protocol based on the vascular anatomy of the nose. Laryngoscope. 2012;122:1210\u20134.","journal-title":"Laryngoscope"},{"key":"586_CR15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.amjoto.2010.06.003","volume":"32","author":"L Bruschini","year":"2011","unstructured":"Bruschini L, Seccia V, Dallan I. A silicone nasal swab for the treatment of severe and recalcitrant epistaxis in hereditary hemorrhagic telangiectasia: an alternative to surgical nostril closure. Am J Otolaryngol. 2011;32:301\u20133.","journal-title":"Am J Otolaryngol"},{"key":"586_CR16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/ajmg.a.35309","volume":"158","author":"AO Geirdal","year":"2012","unstructured":"Geirdal AO, Dheyauldeen S, Bachmann-Harildstad GG, Heimdal K. Quality of life in patients with hereditary hemorrhagic telangiectasia in Norway: a population based study. Am J Med Genet A. 2012;158:1269\u201378.","journal-title":"Am J Med Genet A"},{"key":"586_CR17","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.otohns.2006.12.019","volume":"136","author":"UW Geisthoff","year":"2007","unstructured":"Geisthoff UW, Heckmann K, D\u2019Amelio R, et al. Health related quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg. 2007;136:726\u201333.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"586_CR18","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1007\/s11136-004-7865-y","volume":"13","author":"G Pasculli","year":"2004","unstructured":"Pasculli G, Resta F, Guastamacchia E, Di Genaro L, Suppressa P, Sabb\u00e1 C. Health related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu Osler Weber disease. Qual Life Res. 2004;13:1715\u201323.","journal-title":"Qual Life Res"},{"key":"586_CR19","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/lary.20818","volume":"4","author":"JB Hoag","year":"2010","unstructured":"Hoag JB, Terry P, Mitchell S, Reh D, Merlo CA. An epistaxis severity score for hereditary hemorrhagic telangiectasia. Laryngoscope. 2010;4:838\u201343.","journal-title":"Laryngoscope"},{"key":"586_CR20","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/alr.21374","volume":"11","author":"CA Merlo","year":"2014","unstructured":"Merlo CA, Yin LX, Hoag JB, Mitchell SE, Reh DD. The effects of epistaxis on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Int Forum Allergy Rhinol. 2014;11:921\u20135.","journal-title":"Int Forum Allergy Rhinol"},{"key":"586_CR21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4193\/Rhino09.138","volume":"49","author":"I Ingrand","year":"2011","unstructured":"Ingrand I, Ingrand P, Gilbert-Dussardier B, et al. Altered quality of life in Rendu-Osler-Weber disease related to recurrent epistaxis. Rhinology. 2011;49:155\u201362.","journal-title":"Rhinology"},{"key":"586_CR22","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0168-8510(90)90421-9","volume":"16","author":"EuroQol group","year":"1990","unstructured":"EuroQol group. EuroQol, a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199\u2013208.","journal-title":"Health Policy"},{"key":"586_CR23","unstructured":"Encuesta Nacional de Salud de Espa\u00f1a. Subdirecci\u00f3n General de Informaci\u00f3n Sanitaria e Innovaci\u00f3n. Ministerio de Sanidad y Consumo 2013. URL disponible en: http:\/\/www.msssi.gob.es\/estadEstudios\/estadisticas\/encuestaNacional\/encuesta2011.htm"},{"key":"586_CR24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3109\/09638288.2012.690500","volume":"35","author":"A\u00d8 Geirdal","year":"2013","unstructured":"Geirdal A\u00d8, Dheyauldeen S, Bachmann-Harildstad G, Heimdal K. Living with hereditary haemorrhagic telangiectasia: coping and psychological distress-a cross sectional study. Disabil Rehabil. 2013;35:206\u201313.","journal-title":"Disabil Rehabil"},{"key":"586_CR25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0015-0282(02)04844-6","volume":"3","author":"S Caruso","year":"2003","unstructured":"Caruso S, Roccasalva L, Di Fazio E, et al. Cytologis aspects of the nasal respiratory epithelium in postmenopausal women treated with hormone therapy. Fertil Steril. 2003;3:543\u20139.","journal-title":"Fertil Steril"},{"key":"586_CR26","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.fertnstert.2005.06.029","volume":"6","author":"GD Azevedo","year":"2005","unstructured":"Azevedo GD, Franco RF, Baggio MS, Maranhao TM, S\u00e1 MF. Procoagulant state after raloxifene therapy in postmenopausal women. Fertil Steril. 2005;6:1680\u20134.","journal-title":"Fertil Steril"},{"key":"586_CR27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1160\/TH11-11-0809","volume":"108","author":"V Albi\u00f1ana","year":"2010","unstructured":"Albi\u00f1ana V, Bernabeu-Herrero ME, Zarrabeitia R, Bernabeu C, Botella LM. Estrogen therapy for hereditary haemorrhagic telangiectasia (HHT): effects of raloxifene on endogline and ALK1 expression in endotelial cells. Thromb Haemost. 2010;108:41\u201353.","journal-title":"Thromb Haemost"},{"key":"586_CR28","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1080\/00016480802468138","volume":"129","author":"M Pfister","year":"2009","unstructured":"Pfister M, Zalaman IM, Blumenstock G, Mauz PS, Baumann I. Impact of genotype and mutation type on health-related quality of life in patients with hereditary hemorrhagic telangiectasia. Acta Otolaryngol. 2009;129:862\u20136.","journal-title":"Acta Otolaryngol"},{"key":"586_CR29","first-page":"547","volume":"18","author":"M Serra","year":"2015","unstructured":"Serra M, Scarano C, Giunta D. Quality of life in patients with hereditary hemorrhagic telangiectasia (Rendu Osler Weber syndrome). Angiogenesis. 2015;18:547.","journal-title":"Angiogenesis"}],"container-title":["Health and Quality of Life Outcomes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12955-017-0586-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T15:03:34Z","timestamp":1658502214000},"score":1,"resource":{"primary":{"URL":"http:\/\/hqlo.biomedcentral.com\/articles\/10.1186\/s12955-017-0586-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["586"],"URL":"https:\/\/doi.org\/10.1186\/s12955-017-0586-z","relation":{},"ISSN":["1477-7525"],"issn-type":[{"value":"1477-7525","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"article-number":"19"}}